The present disclosure is generally directed to packages that include at least one medicament therein. The packages generally include at least one light or lighted member affixed thereto that is capable of emitting light upon activation. In many embodiments as described herein, the light or lighted member is activated upon the opening of the package such that upon opening, the light or lighted member fluoresces or otherwise emits light to provide information to an end user. In some embodiments, the light generated by the light or lighted member allows the end user to locate the package in dark conditions. In other embodiments, the light generated by the light or lighted member may be configured such that it is emitted only for a time period equal to the viability time period of the medicament contained within the package to alert an end user that the medicament is no longer useable. In still other embodiments, the light generated by the light or lighted member may be configured such that it changes color at a time period equal to the viability time period of the medicament contained within the package to alert an end user that the medicament is no longer useable.La présente invention concerne de manière générale des emballages qui comprennent au moins un médicament en leur sein. Les emballages comprennent généralement au moins un élément lumineux ou éclairé qui y est fixé, qui est en mesure démettre de la lumière lors de lactivation. Dans de nombreux modes de réalisation tels que décrits dans la description, lélément lumineux ou éclairé est activé lors de louverture de lemballage, de telle sorte que, lors de louverture, lélément lumineux ou éclairé émet une fluorescence ou une autre lumière pour fournir des informations à un utilisateur final. Dans certains modes de réalisation, la lumière générée par lélément lumineux ou éclairé permet à lutilisateur final de localiser lemballage dans des conditions dobscurité. Dans dautres modes de réalisation, la lumière générée
